- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03277625
Modified Reconstruction for Pancreatic Head Resection
Safety and Efficacy of Modified Single-loop Omega-shaped Reconstruction After Pancreaticoduodenectomy in Patients With High-risk Pancreas
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Postoperative pancreatic fistula (POPF) is the most common and specific complication of pancreaticoduodenectomy (PD) with reported rates of over 20% even at high-volume centers. POPF may cause life-threatening secondary complications such as postpancreatectomy hemorrhage (PPH), intraabdominal abscess, and sepsis, leading to increased costs, prolonged hospital stay as well as to delayed chemotherapy in oncologic patients.
A myriad of innovations in surgical technique has been introduced over the last several decades in order to reduce the rate and severity of POPF. One of these includes the double-loop (DL) reconstruction with isolated Roux-en-Y loops for the pancreatic and biliary anastomoses. It was first described in 1976 by Machado and has afterwards been applied by many surgeons in different variations. The method is based on the empirical hypothesis that diverting bile away from pancreatic juice may prevent their mutual activation and thus decrease their aggressiveness and detrimental effect on the pancreaticojejunostomy (PJ). Theoretically, reduction in the rate and severity of POPF should be expected. Some randomized controlled trials (RCT) reported decreased severity of POPF and lower rates of associated morbidity, whereas others failed to confirm these positive results. A substantially prolonged duration of surgery was observed in most of the studies.
In order to reduce the rate and severity of POPF without prolonging duration of surgery, we introduced in 2015 a new method of reconstruction during PD using a single long intestinal loop with a side-to-side anastomosis between the afferent and efferent limbs of the hepaticojejunostomy (HJ) similar to a Braun anastomosis in a Billroth II resection. It aimed at increasing the distance between the pancreatic and biliary anastomotic sites and facilitating isolated flow of bile and pancreatic secretions in a simple, fast and straightforward manner without the need for a time-consuming and sometimes technically challenging DL reconstruction.
This study aims to reveal how the new modified single-loop (mSL) method of reconstruction compares to the conventional single loop (SL) and DL methods in terms of severity and rate of POPF as well as associated major complications after PD in high-risk patients with a soft pancreatic remnant and a small pancreatic duct.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
NRW
-
Bochum, NRW, Germany, 44791
- Recruiting
- Department of Surgery, St. Josef Hospital, Ruhr University of Bochum
-
Contact:
- Orlin Belyaev, MD
- Phone Number: +49 234 509 0
- Email: o.belyaev@klinikum-bochum.de
-
Contact:
- Waldemar Uhl, MD, PhD
- Phone Number: +49 234 509 2211
- Email: w.uhl@klinikum-bochum.de
-
Principal Investigator:
- Ilgar Aghalarov
-
Principal Investigator:
- Orlin Belyaev, MD
-
Principal Investigator:
- Waldemar Uhl, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- pancreaticoduodenectomy
- soft, fragile or fatty pancreatic remnant combined with pancreatic duct <3mm
Exclusion Criteria:
- soft pancreas, but large pancreatic duct>3mm
- small pancreatic duct <3mm, but hard pancreatic remnant
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
pancreaticoduodenectomy
patients undergoing pancreticoduodenectomy and having a soft, fragile and/or fatty pancreatic remnant, combined with small pancreatic duct having a Diameter <3 mm.
|
A double-layer, end-to-side, duct-to-mucosa PJ using interrupted polydioxanone 5-0 suture (PDS II, Ethicon, Somerville, USA) for the outer layer and interrupted polypropylene 5-0 suture (Prolene, Ethicon, USA) for the inner layer is the standard technique during PD at our Institution.
For the modified omega-shaped single-Loop reconstruction the loop between PJ and HJ is left intentionally longer at about 25-30 cm and an additional side-to-side jejunojejunal anastomosis is performed at the lowest point between the afferent and efferent loops of the HJ This intestinal anastomosis is done in a double-layer continuous PDS 5-0 suture technique.
Neither sealants, nor stents are being applied at the PJ.
In cases of thin walled and tiny hepatic ducts, the HJ is splinted using an externally diverted T-tube.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Severity of postoperative pancreatic fistula
Time Frame: from postoperative day 3 until postoperative day 30
|
grade B and grade C Fistula as clinically relevant
|
from postoperative day 3 until postoperative day 30
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Major postoperative complications
Time Frame: postoperative days 1 to 30
|
all type of postoperative complications grades 3b, 4 and 5 (mortality) after Dindo-Clavien
|
postoperative days 1 to 30
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-5706
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreaticoduodenal; Fistula
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingPancreatic Fistula | Pancreaticoduodenal; FistulaChina
-
West China HospitalCompletedPerioperative Complication | Pancreaticoduodenal; Fistula | Surgery TimingChina
-
University of WashingtonCompletedPancreatectomy; Hyperglycemia | Pancreatic Fistula | Pancreaticoduodenal; Fistula | Pancreatic LeakUnited States
-
Oslo University HospitalCompletedPancreatic Cancer | Pancreatic Fistula | Pancreaticoduodenal; Fistula | Pancreas; Fistula
-
National and Kapodistrian University of AthensRecruitingAnal Fistula | Perianal Fistula | Anal Fistula SurgeryGreece
-
London North West Healthcare NHS TrustCompletedFistula in Ano | Ano FistulaUnited Kingdom
-
Rush University Medical CenterTerminatedRectal Fistula | Anal Fistula | Fistula in Ano | Transsphincteric FistulaUnited States
-
William A. Faubion, M.D.CompletedPerianal Fistula | Cryptoglandular Perianal Fistula | Crohn's Perianal FistulaUnited States
-
Tehran University of Medical SciencesNot yet recruiting
-
University Hospital, AkershusUniversity Hospital, Linkoeping; Region Örebro County; Uppsala University HospitalCompletedPerianal FistulaNorway
Clinical Trials on modified omega-shaped single-loop
-
Fatih Sultan Mehmet Training and Research HospitalCompletedOsteoarthritis, KneeTurkey (Türkiye)
-
Medical University of ViennaUnknown
-
Inonu UniversityCompletedPancreatic FistulaTurkey
-
Nemocnice Břeclav, p.o.UnknownDiabetes Mellitus, Type 2 | Obesity, SevereCzech Republic
-
Cairo UniversityCompletedEndotracheal Intubation
-
Hospital Universitari de BellvitgeInstituto de Salud Carlos IIIEnrolling by invitationDiabetes Mellitus, Type 2 | Bariatric Surgery Candidate | Severe ObesitySpain
-
Assiut UniversityUnknown
-
Korea University Anam HospitalSeoul National University Hospital; Kyungpook National University Chilgok Hospital and other collaboratorsEnrolling by invitationRectal Cancer | Rectal Neoplasms | Rectal Neoplasms Malignant | Rectal Cancer SurgerySouth Korea
-
FlevoziekenhuisRecruitingObesity | Obesity, Morbid | Bariatric Surgery CandidateNetherlands
-
Yuqing ChenCompleted